|
1）National Kidney Foundation. K/DOQI Clinical Practice Guideline for Chronic Kidney Disease: Evaluation, Classification and Stratification. Sam J Kidny Dis. 2002; 39 (Supple 1): S1-266
|
|
|
|
|
2）Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6): 2089-100
|
|
|
|
|
3）Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80(1): 17-28
|
|
|
|
|
|
4）Levin A, Stevens PE, et al. KDIGO clinical practice guideline for evaluation and management of CKD. Kidney Int. in preparation
|
|
|
|
|
|
5）Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375(9731): 2073-81
|
|
|
|
|
|
6）日本腎臓学会. CKD診療ガイド2012. 東京: 東京医学社; 2012
|
|
|
|
|
|
7）Horio M, Imai E, Yasuda Y, et al. GFR estimate or using standardized serum cystein C in Japan. Am J Kid Pis. 2012 Aug II [Epub ahead of print]
|
|
|
|
|
|
8）Nakayama M, Sato T, Miyazaki M, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res. 2011; 34: 1106-10
|
|
|
|
|
9）日本腎臓学会, 編. CKD診療ガイド2009. 東京: 東京医学社; 2009
|
|
|
|
|